OGN - Organon expects revenue to grow in the low-single-digit range for FY24
2024-01-08 08:02:40 ET
More on Organon
- Organon: What I'm Looking For In This 8% Yield In 2024
- High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
- Organon: It's Darkest Before The Dawn
- EU suggests label update to flag brain-related risks in certain cold drugs
- FDA accepts supplemental application for Humira biosimilar from Samsung Bioepis, Organon
For further details see:
Organon expects revenue to grow in the low-single-digit range for FY24